Get startedLog in
    Picture of Clio Cosmetics Co logo

    237880 — Clio Cosmetics Co Income Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    Consumer DefensivesSpeculativeSmall CapContrarian
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Clio Cosmetics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue218,216232,744272,455330,584351,366
    Cost of Revenue
    Gross Profit111,819112,346134,840166,101171,295
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses211,955222,782256,145300,775326,954
    Operating Profit6,2619,96216,31029,81024,412
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes12,95812,42115,70036,07532,331
    Provision for Income Taxes
    Net Income After Taxes9,5859,26710,12927,31927,156
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income9,5859,26710,12927,69627,865
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Dilution Adjustment
    Diluted Net Income6,4948,92010,12927,69627,865
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS3836926531,7311,599
    Dividends per Share